An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets

Blood

Volumn 118, Issue 20, 2011, Pages 5641-5651

  Nisar, Shaista ^a   Daly, Martina E ^b   Federici, Augusto B ^c   Artoni, Andrea ^d   Mumford, Andrew D ^a   Watson, Stephen P ^e   Mundell, Stuart J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN ZO1; PURINERGIC P2Y12 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; DELETION MUTANT; HUMAN; HUMAN CELL; INTERNALIZATION; MUTATION; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; REGULATORY MECHANISM; THROMBOCYTE; THROMBOCYTE FUNCTION;

EID: 81555228392     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-336826     Document Type: Article

References (34)

1. Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, Quinton TM. ADP receptors-targets for developing antithrombotic agents. Curr Pharm Des. 2003;9(28):2303-2316. (Pubitemid 37242945)
2. Gachet C. P2 receptors, platelet function and pharmacological implications. Thromb Haemost. 2008;99(3):466-472. (Pubitemid 351549282)
3. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADPinduced platelet aggregation. Proc Natl Acad Sci U S A. 1998;95:8070-8074. (Pubitemid 28326067)
4. Mundell SJ, Barton JF, Mayo-Martin MB, Hardy AR, Poole AW. Rapid resensitization of purinergic receptor function in human platelets. J Thromb Haemost. 2008;6(8):1393-1404. (Pubitemid 352022551)
5. Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood. 2005;105(9):3552- 3560.
6. Mundell SJ, Jones ML, Hardy AR, et al. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function. Mol Pharmacol. 2006;70(3):1132-1142. (Pubitemid 44268470)
7. Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic. 2006;7(10):1420-1431. (Pubitemid 44364179)
8. Wolfe BL, Trejo J. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic. 2007;8(5):462-470. (Pubitemid 46638559)
9. Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol. 2008; 48:537-568. (Pubitemid 351738163)
10. Marchese A, Paing MM, Temple BR, Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmacol Toxicol. 2008;48:601-629. (Pubitemid 351738165)
11. Smyth SS, Woulfe DS, Weitz JI, et al. G-proteincoupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2009;29(4):449-457.
12. Matharu AL, Mundell SJ, Benovic JL, Kelly E. Rapid agonist-induced desensitization and internalization of the A(2B) adenosine receptor is mediated by a serine residue close to the COOH terminus. J Biol Chem. 2001;276(32):30199-30207.
13. Mundell SJ, Matharu AL, Pula G, Roberts PJ, Kelly E. Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestinand dynamin-dependent. J Neurochem. 2001;78: 546-551. (Pubitemid 32729982)
14. Cattaneo M, Zighetti ML, Lombardi R, et al. Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci U S A. 2003; 100(4):1978-1983. (Pubitemid 36254559)
15. Daunt DA, Hurt C, Hein L, Kallio J, Feng F, Kobilka BK. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol. 1997;51(5):711-720. (Pubitemid 27224676)
16. Krupnick JG, Santini F, Gagnon AW, Keen JH, Benovic JL. Modulation of the arrestin-clathrin interaction in cells. Characterization of b-arrestin dominat negative mutants. J Biol Chem. 1997; 272:32507-32512. (Pubitemid 28011936)
17. Benmerah A, Poupon V, Cerf-Bensussan N, Dautry-Varsat A. Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J Biol Chem. 2000;275(5):3288-3295. (Pubitemid 30083030)
18. Damke H, Baba T, Warnock DE, Schmid SL. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol. 1994;127:915-934. (Pubitemid 24355982)
19. Daly ME, Dawood BB, Lester WA, et al. Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study. Blood. 2009;113(17):4110-4113.
20. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood. 2007;109(1):112-121. (Pubitemid 46053051)
21. Kunicki TJ, Federici AB, Salomon DR, et al. An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood. 2004;104(8): 2359-2367. (Pubitemid 39331834)
22. Remijn JA, IJsselkijk MJ, Strunk AL, et al. Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis. Clin Chem Lab Med. 2007;45(2):187-189.
23. Mumford AD, Dawood BB, Daly ME, et al. A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis. Blood. 2010;115(2):363-369.
24. Watson S, Daly M, Dawood B, et al. Phenotypic approaches to gene mapping in platelet function disorders-identification of new variant of P2Y12, TxA2 and GPVI receptors. Hamostaseologie. 2010;30(1):29-38.
25. Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood. 2006;108(9): 3045-3052.
26. Goto S, Tamura N, Ishida H, Ruggeri ZM. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5′-diphosphate receptor stimulation and cyclic calcium signaling. J Am Coll Cardiol. 2006;47(1): 155-162. (Pubitemid 43005180)
27. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2- adrenergic receptor. Nature. 1999;401:286-290.
28. Gage RM, Matveeva EA, Whiteheart SW, von Zastrow M. Type I PDZ ligands are sufficient to promote rapid recycling of G Protein-coupled receptors independent of binding to N-ethylmaleimide- sensitive factor. J Biol Chem. 2005;280(5): 3305-3313. (Pubitemid 40223792)
29. Paasche JD, Attramadal T, Kristiansen K, et al. Subtype-specific sorting of the ETA endothelin receptor by a novel endocytic recycling signal for G protein-coupled receptors. Mol Pharmacol. 2005;67(5):1581-1590. (Pubitemid 40594157)
30. Lauffer BE, Melero C, Temkin P, et al. SNX27 mediates PDZ-directed sorting from endosomes to the plasma membrane. J Cell Biol. 2010;190(4): 565-574.
31. Li D, D'Angelo L, Chavez M, Woulfe DS. Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. J Biol Chem. 2011; 286(5):3805-3814.
32. DeFea KA. Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal. 2011;23(4): 621-629.
33. Popova JS, Rasenick MM. Clathrin-mediated endocytosis of m3 muscarinic receptors. Roles for Gbetagamma and tubulin. J Biol Chem. 2004; 279(29):30410-30418. (Pubitemid 38937969)
34. Diviani D, Lattion AL, Abuin L, Staub O, Cotecchia S. The adaptor complex 2 directly interacts with the alpha 1b-adrenergic receptor and plays a role in receptor endocytosis. J Biol Chem. 2003;278(21):19331-19340. (Pubitemid 36799327)